AVIDITY BIOSCIENCES INC. 2024-2025 Proxy Voting Records

Description as filed by funds: To elect Class II directors for a three-year term that expires at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Arthur Levin, Ph.D.

AVIDITY BIOSCIENCES INC.’s own tally for this item (“Elect Director: Arthur A. Levin, Ph.D.”): 107,228,713 for, 3,977,391 withheld, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 71 asset managers below reported 47,830,271 for, 1,418,519 withheld, 0 abstained, 65 not voted.

Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.

Description as filed by funds: To elect Class II directors for a three-year term that expires at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Simona Skerjanec

AVIDITY BIOSCIENCES INC.’s own tally for this item (“Elect Director: Simona Skerjanec”): 110,454,102 for, 812,002 withheld, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 71 asset managers below reported 49,082,176 for, 166,614 withheld, 0 abstained, 65 not voted.

Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.

Description as filed by funds: To elect Class II directors for a three-year term that expires at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Tamar Thompson

AVIDITY BIOSCIENCES INC.’s own tally for this item (“Elect Director: Tamar Thompson”): 80,562,501 for, 30,703,603 withheld, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 72% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 71 asset managers below reported 38,090,315 for, 11,158,475 withheld, 0 abstained, 65 not voted.

Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.

Description as filed by funds: To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and

AVIDITY BIOSCIENCES INC.’s own tally for this item (“3. The approval, on an advisory basis, of the compensation of the Company's named executive officers as described in the proxy statement related to the 2025 Annual Meeting”): 80,649,100 for, 25,309,060 against — passed, per its Form 8-K filed June 10, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The compensation of the named executive officers was approved, on an advisory basis, by the votes indicated:”
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of AVIDITY BIOSCIENCES INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (9 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 71 managers: 40,308,469 for, 8,933,084 against, 7,237 abstained, 65 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 184 managers: 68,278,566 for, 15,389,065 against, 30,830 abstained, 4,078 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as our independent public accounting firm for the fiscal year ending December 31, 2025;

AVIDITY BIOSCIENCES INC.’s own tally for this item (“2. The ratification of the appointment of Deloitte & Touche, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 116,729,544 for, 31,495 against — passed, per its Form 8-K filed June 10, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The appointment was ratified by the votes indicated:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 49,365,186 for, 1,367 against, 7,237 abstained, 65 not voted.

Showing the 25 largest of 74 asset managers. See all 74 in the interactive database.